In this issue:
Boceprevir in previously treated HCV GT1 infection
Boceprevir in previously untreated HCV GT1 infection
Escitalopram prevents IFN-α-associated depression
BOC- and TVR-based triple therapy in cirrhotics
Broader screening for HCV?
HCV positivity and insulin resistance/diabetes
Stopping rule for PEG-IFN in CHB
Silymarin: no benefit in chronic HCV
PSI-7977/RBV in HCV GT1/2/3
Daclatasvir/GS-7977 ±RBV for untreated chronic HCV GT1/2/3
Please login below to download this issue (PDF)